John F. Kurland

John F. Kurland presented about immuno-oncology therapies at the IO360 Summit

John F. Kurland, VP of Global Head of Strategic Regimens at AstraZeneca, posted on LinkedIn:

“I am excited to report back from Boston and the IO360 Summit, where I spoke about advancements in immuno-oncology therapies.

This event offered a valuable opportunity to interact with colleagues, to learn about emerging approaches, and to explore ways of collaborating in our mission to improve patient outcomes.”
AstraZeneca cancer immuno-oncology therapies IO360 Summit John F. Kurland OncoDaily Oncology